Literature DB >> 27702934

Efficacy of extracorporeal ultrafiltration in patients with diuretic-resistant heart failure.

Naomi Nakazawa1, Keisuke Nakabayashi2, Toshiaki Oka2.   

Abstract

Renal congestion contributes to the cardiorenal syndrome. There are some heart failure cases that are refractory to diuretic therapy. If the dose of diuretics is titrated, it leads to irreversible renal dysfunction. Early administration of tolvaptan is effective in treating fluid retention and congestion. However, in case of tolvaptan resistance, starting extracorporeal ultrafiltration (ECUM) at an early stage should be considered. Tolvaptan has been proven efficient, and we believe it should be incorporated with the classical method, ECUM. Herein, we present a case of successful application of ECUM to a heart failure patient refractory to any diuretics and tolvaptan. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27702934      PMCID： PMC5073608          DOI： 10.1136/bcr-2016-217301

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

Review 1.  Diuretics and ultrafiltration in acute decompensated heart failure.

Authors:  G Michael Felker; Robert J Mentz
Journal:  J Am Coll Cardiol       Date:  2012-06-12       Impact factor: 24.094

2.  The cardiorenal syndrome: do we need a change of strategy or a change of tactics?

Authors:  Mariell Jessup; Maria Rosa Costanzo
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

Review 3.  Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.

Authors:  Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2010-03-30       Impact factor: 15.534

4.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Kirkwood F Adams; Gregg C Fonarow; Charles L Emerman; Thierry H LeJemtel; Maria Rosa Costanzo; William T Abraham; Robert L Berkowitz; Marie Galvao; Darlene P Horton
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

5.  Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions.

Authors:  Manu L N G Malbrain; Michael L Cheatham; Andrew Kirkpatrick; Michael Sugrue; Michael Parr; Jan De Waele; Zsolt Balogh; Ari Leppäniemi; Claudia Olvera; Rao Ivatury; Scott D'Amours; Julia Wendon; Ken Hillman; Kenth Johansson; Karel Kolkman; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2006-09-12       Impact factor: 17.440

6.  Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

Authors:  Maria Rosa Costanzo; Maya E Guglin; Mitchell T Saltzberg; Mariell L Jessup; Bradley A Bart; John R Teerlink; Brian E Jaski; James C Fang; Erika D Feller; Garrie J Haas; Allen S Anderson; Michael P Schollmeyer; Paul A Sobotka
Journal:  J Am Coll Cardiol       Date:  2007-01-26       Impact factor: 24.094

7.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

Review 8.  Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.

Authors:  Claudio Ronco; Mariantonietta Cicoira; Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2012-07-25       Impact factor: 24.094

Review 9.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Luca Di Lullo
Journal:  Heart Fail Clin       Date:  2014-02-04       Impact factor: 3.179

10.  Diuretic resistance predicts mortality in patients with advanced heart failure.

Authors:  Gerald W Neuberg; Alan B Miller; Chris M O'Connor; Robert N Belkin; Peter E Carson; Anne B Cropp; David J Frid; Regina G Nye; Milton L Pressler; John H Wertheimer; Milton Packer
Journal:  Am Heart J       Date:  2002-07       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.